New Owner
Valeant Pharmaceuticals International - Dow Pharmaceutical Sciences
Valeant Pharmaceuticals International acquires Dow Pharmaceutical Sciences
Announced: December 31, 2008
Type: Acquisition
Status: Complete
Amount: $ 285,000,000